Netherlands' IMCD nine-month profit up 20%

By Reuters News


Overview

  • Netherlands specialty chemicals distributor's nine-month revenue rose 10% on a constant currency basis

  • Net result for the period increased 20% on a constant currency basis

  • Company cites sustained business momentum and 14% organic EBITA growth in Q3


Outlook

  • Company expects organic EBITA growth for the full yr


Result Drivers

  • BUSINESS MOMENTUM - Co said sustained business momentum and 14% organic EBITA growth in Q3 drove results

  • INITIATIVES - Co attributed performance to ongoing commercial, operational and digital excellence initiatives


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

9M Net Income

EUR 211 mln

9M EBITA

EUR 425 mln

9M Free Cash Flow

EUR 317 mln

9M Gross Profit

EUR 991 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for IMCD N.V. is €121.00, about 15.8% above its November 4 closing price of €104.50

  • The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • Nov 3 - Switzerland's Clariant Q3 sales beat on higher prices, EBITDA misses on cost pressure

  • Nov 4 - Solvay Q3 revenue falls on soda ash weakness

  • Nov 3 - German chemical sector mood slips in October after two-month recovery, Ifo says


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.